Distal embolisation during carotid stenting is predicted by circulating levels of LDL cholesterol and C-reactive protein

EuroIntervention 2014;10:513-517. DOI: 10.4244/EIJV10I4A88

Bernardo Cortese
Bernardo Cortese1*, MD; Marco De Carlo2, MD; Sara De Matteis3, MD; Antonio Rizza4, MD; Danilo Giannini2, MD; Cataldo Palmieri4, MD; Anna Sonia Petronio2, MD; Sergio Berti4, MD; Alberto Balbarini2, MD; Steve Ramee5, MD
1. Interventional Cardiology, A.O. Fatebenefratelli, Milan, Italy; 2. Azienda Ospedaliero - Universitaria Pisana, Pisa, Italy; 3. Department of Preventive Medicine, Fondazione IRCCS Ca’ Granda - Ospedale Maggiore Policlinico & Department of Clinical S

Aims: Distal embolisation during carotid artery stenting (CAS) is the main cause of cerebral complications; thus, the amount of embolisation occurring during CAS can be considered as a su

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

carotid artery stentingc-reactive proteindistal embolisationlow-density lipoproteinstatin
Read next article
Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension

Latest news